Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

The White House March 13 withdrew the nomination of former Republican congressman Dave Weldon for director of the Centers for ...

In a Q&A, NIH addiction chief Nora Volkow speaks about RFK Jr.'s policy shake-ups, 12-step recovery limits, and why overdose ...

The Senate Health, Education, Labor, & Pensions (HELP) Committee voted Thursday to recommend that the Senate confirm ...

Two of President Donald Trump’s key public health nominations advanced at the committee level Thursday morning, moving them ...

The Senate Health, Education, Labor, and Pensions Committee approved Dr. Jayanta Bhattacharya’s nomination to be NIH director ...

The Senate Committee of Health, Education, Labor and Pensions voted to approve Jay Bhattacharya as director of the National Institutes of Health on Wednesday. He now faces a glide-path to ...

Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.

FDA commissioner nominee Marty Makary, a Johns Hopkins Medicine surgeon, and NIH pick Jay Bhattacharya, a Stanford University health economist and doctor, sailed through the committee.

A Senate committee voted Thursday morning to advance Dr. Jay Bhattacharya, President Donald Trump's pick to head the National ...

President Donald Trump's nominee to lead the Food and Drug Administration (FDA), Dr. Marty Makary, passed a key committee vote on Thursday morning.

NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions. Colorized transmission electron micrograph of immature mpox virus particles (blue with red viral envelope) ...